Daratumumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: extended follow-up of POLLUX, a randomized, open-label, phase 3 study

Nizar J. Bahlis; Meletios A. Dimopoulos; Darrell J. White; Lotfi Benboubker; Gordon Cook; Merav Leiba; P. Joy Ho; Kihyun Kim; Naoki Takezako; Philippe Moreau; Jonathan L. Kaufman; Maria Krevvata; Christopher Chiu; Xiang Qin; Linda Okonkwo; Sonali Trivedi; Jon Ukropec; Ming Qi; Jesus San-Miguel

doi:10.1038/s41375-020-0711-6

Daratumumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: extended follow-up of POLLUX, a randomized, open-label, phase 3 study

Nizar J. Bahlis, Meletios A. Dimopoulos, Darrell J. White, Lotfi Benboubker, Gordon Cook, Merav Leiba, P. Joy Ho, Kihyun Kim, Naoki Takezako, Philippe Moreau, Jonathan L. Kaufman, Maria Krevvata, Christopher Chiu, Xiang Qin, Linda Okonkwo, Sonali Trivedi, Jon Ukropec, Ming Qi, Jesus San-Miguel

科研成果: 期刊稿件 › 文章 › 同行评审

188 引用（Scopus）

源语言	英语
页（从-至）	1875-1884
页数	10
期刊	Leukemia
卷	34
期	7
DOI	https://doi.org/10.1038/s41375-020-0711-6
出版状态	已出版 - 7月 1 2020
已对外发布	是

!!!ASJC Scopus Subject Areas

血液学
肿瘤学
癌症研究

联合国可持续发展目标

此成果有助于实现下列可持续发展目标：

访问文件

10.1038/s41375-020-0711-6

其它文件与链接

引用此

Bahlis, N. J., Dimopoulos, M. A., White, D. J., Benboubker, L., Cook, G., Leiba, M., Ho, P. J., Kim, K., Takezako, N., Moreau, P., Kaufman, J. L., Krevvata, M., Chiu, C., Qin, X., Okonkwo, L., Trivedi, S., Ukropec, J., Qi, M., & San-Miguel, J. (2020). Daratumumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: extended follow-up of POLLUX, a randomized, open-label, phase 3 study. Leukemia, 34(7), 1875-1884. https://doi.org/10.1038/s41375-020-0711-6

Bahlis, NJ, Dimopoulos, MA, White, DJ, Benboubker, L, Cook, G, Leiba, M, Ho, PJ, Kim, K, Takezako, N, Moreau, P, Kaufman, JL, Krevvata, M, Chiu, C, Qin, X, Okonkwo, L, Trivedi, S, Ukropec, J, Qi, M & San-Miguel, J 2020, 'Daratumumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: extended follow-up of POLLUX, a randomized, open-label, phase 3 study', Leukemia, 卷 34, 号码 7, 页码 1875-1884. https://doi.org/10.1038/s41375-020-0711-6

@article{b4462058ea5a4a9d862559b4e9eeddee,

title = "Daratumumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: extended follow-up of POLLUX, a randomized, open-label, phase 3 study",

author = "Bahlis, {Nizar J.} and Dimopoulos, {Meletios A.} and White, {Darrell J.} and Lotfi Benboubker and Gordon Cook and Merav Leiba and Ho, {P. Joy} and Kihyun Kim and Naoki Takezako and Philippe Moreau and Kaufman, {Jonathan L.} and Maria Krevvata and Christopher Chiu and Xiang Qin and Linda Okonkwo and Sonali Trivedi and Jon Ukropec and Ming Qi and Jesus San-Miguel",

note = "Publisher Copyright: {\textcopyright} 2020, The Author(s).",

year = "2020",

month = jul,

day = "1",

doi = "10.1038/s41375-020-0711-6",

language = "English",

volume = "34",

pages = "1875--1884",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "7",

}

TY - JOUR

T1 - Daratumumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma

T2 - extended follow-up of POLLUX, a randomized, open-label, phase 3 study

AU - Bahlis, Nizar J.

AU - Dimopoulos, Meletios A.

AU - White, Darrell J.

AU - Benboubker, Lotfi

AU - Cook, Gordon

AU - Leiba, Merav

AU - Ho, P. Joy

AU - Kim, Kihyun

AU - Takezako, Naoki

AU - Moreau, Philippe

AU - Kaufman, Jonathan L.

AU - Krevvata, Maria

AU - Chiu, Christopher

AU - Qin, Xiang

AU - Okonkwo, Linda

AU - Trivedi, Sonali

AU - Ukropec, Jon

AU - Qi, Ming

AU - San-Miguel, Jesus

PY - 2020/7/1

Y1 - 2020/7/1

UR - http://www.scopus.com/inward/record.url?scp=85078714617&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85078714617&partnerID=8YFLogxK

U2 - 10.1038/s41375-020-0711-6

DO - 10.1038/s41375-020-0711-6

M3 - Article

C2 - 32001798

AN - SCOPUS:85078714617

SN - 0887-6924

VL - 34

SP - 1875

EP - 1884

JO - Leukemia

JF - Leukemia

IS - 7

ER -

Daratumumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: extended follow-up of POLLUX, a randomized, open-label, phase 3 study

!!!ASJC Scopus Subject Areas

联合国可持续发展目标

访问文件

其它文件与链接

指纹

引用此